Paris, France, April 21, 2021 – 18.00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have ...
These results pave the way to prosthetic vision with acuity exceeding 20/100, over five times higher than the current best prosthetic acuity, and with electronic magnification, it may reach 20/20. The ...
Pixium Vision completes implantation of PRIMA in five patients with atrophic dry-AMD as expected for the feasibility clinical trial in France Paris, France. July 10, 2018 - 7.00 AM CEST - Pixium ...
Please provide your email address to receive an email when new articles are posted on . The PRIMAvera study evaluated the safety and efficacy of the Prima implant in patients with foveal-involving ...
Conversion of 160 ORNAN2022 by ESGO with intention to pursue controlled trading of shares Cost reduction measures implemented potentially extending the cash runway beyond the end of Q2 2023 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results